Help your patients meet their nutrition goals with Encala

Encala is a clinically proven medical food, specially formulated for patients with cystic fibrosis (CF) or other diseases where pancreatic insufficiency is present and gaining and maintaining weight, height and BMI is a challenge. It’s a taste-neutral mixable powder that works in two ways:

  • Encala provides highly absorbable fat calories and essential fatty acids to meals, beverages, or snacks.
  • Encala enables your patient’s body to better absorb the fat and fat-soluble vitamins that are already in the food they’re eating.1,2

In an NIH-sponsored clinical study of 110 CF patients with exocrine pancreatic insufficiency (EPI), Encala1,2

  • Increased the coefficient of fat absorption (CFA) by a mean of 6% (82% to 88%) over 3 months and demonstrated improvement in blood levels for essential fatty acids, vitamins A and K, and choline2
  • Elevated CFA 8% over baseline at 3 months among patients with a mean baseline of 77% CFA
  • Increased weight, height, and BMI in only 3 months, versus no change in the group taking an active placebo (a calorically similar supplement used for comparison)

Learn how adding Encala can help your patients with CF or EPI

See how Encala works through its mechanism of action

See clinical data from the NIH-sponsored active placebo-controlled study

Download a reimbursement support form

Scroll to Top

A new code has been created and issued for Encala by the Centers of Medicare and Medicaid Services (CMS).

Learn More